Clements Ian's Form 4 filing
Mirum Pharmaceuticals, Inc. (MIRM) · filed Nov 29, 2021
- Accession no.
- 0001209191-21-067068
- Filed
- Nov 29, 2021
- Trade date
- Nov 24-26, 2021
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $20.5K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Clements IanCIK 0001780080 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 24, 2021 | Common Stock | PPurchaseAcquired | +700 | $14.40 | +$10,080 | 17,811 | Direct | |
| Nov 26, 2021 | Common Stock | PPurchaseAcquired | +750 | $13.90 | +$10,425 | 18,561 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.